Intrinsic value of Omega Healthcare Investors - OHI

Previous Close

$32.72

  Intrinsic Value

$7.17

stock screener

  Rating & Target

str. sell

-78%

Previous close

$32.72

 
Intrinsic value

$7.17

 
Up/down potential

-78%

 
Rating

str. sell

Our model is not good at valuating stocks of financial companies, such as OHI.

We calculate the intrinsic value of OHI stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2017), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 6.5

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046
   2047

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  2.00
  2.30
  2.57
  2.81
  3.03
  3.23
  3.41
  3.57
  3.71
  3.84
  3.95
  4.06
  4.15
  4.24
  4.31
  4.38
  4.44
  4.50
  4.55
  4.59
  4.64
  4.67
  4.70
  4.73
  4.76
  4.78
  4.81
  4.83
  4.84
  4.86
Revenue, $m
  926
  947
  972
  999
  1,029
  1,063
  1,099
  1,138
  1,180
  1,226
  1,274
  1,326
  1,381
  1,439
  1,501
  1,567
  1,637
  1,710
  1,788
  1,870
  1,957
  2,049
  2,145
  2,246
  2,353
  2,466
  2,585
  2,709
  2,840
  2,978
Variable operating expenses, $m
  402
  411
  422
  434
  447
  461
  477
  494
  512
  532
  553
  575
  599
  625
  652
  680
  710
  742
  776
  812
  849
  889
  931
  975
  1,021
  1,070
  1,122
  1,176
  1,233
  1,293
Fixed operating expenses, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  402
  411
  422
  434
  447
  461
  477
  494
  512
  532
  553
  575
  599
  625
  652
  680
  710
  742
  776
  812
  849
  889
  931
  975
  1,021
  1,070
  1,122
  1,176
  1,233
  1,293
Operating income, $m
  524
  536
  550
  566
  583
  601
  622
  644
  668
  694
  721
  750
  782
  815
  850
  887
  926
  968
  1,012
  1,059
  1,108
  1,159
  1,214
  1,272
  1,332
  1,396
  1,463
  1,533
  1,608
  1,686
EBITDA, $m
  1,428
  1,461
  1,498
  1,540
  1,587
  1,638
  1,694
  1,754
  1,819
  1,889
  1,964
  2,044
  2,128
  2,219
  2,314
  2,416
  2,523
  2,637
  2,757
  2,883
  3,017
  3,158
  3,306
  3,463
  3,628
  3,801
  3,984
  4,176
  4,379
  4,591
Interest expense (income), $m
  148
  418
  418
  418
  418
  418
  418
  419
  419
  419
  419
  419
  419
  419
  419
  419
  419
  419
  420
  420
  420
  420
  420
  420
  420
  421
  421
  421
  421
  421
  422
Earnings before tax, $m
  106
  118
  132
  147
  164
  183
  203
  226
  249
  275
  302
  331
  363
  396
  431
  468
  507
  549
  592
  639
  688
  739
  794
  851
  911
  975
  1,042
  1,112
  1,186
  1,264
Tax expense, $m
  29
  32
  36
  40
  44
  49
  55
  61
  67
  74
  82
  89
  98
  107
  116
  126
  137
  148
  160
  172
  186
  200
  214
  230
  246
  263
  281
  300
  320
  341
Net income, $m
  77
  86
  96
  107
  120
  134
  149
  165
  182
  201
  221
  242
  265
  289
  314
  341
  370
  400
  433
  466
  502
  540
  579
  621
  665
  712
  761
  812
  866
  923

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  -1,397
  -1,429
  -1,466
  -1,507
  -1,553
  -1,603
  -1,657
  -1,717
  -1,780
  -1,848
  -1,922
  -2,000
  -2,083
  -2,171
  -2,264
  -2,364
  -2,469
  -2,580
  -2,697
  -2,821
  -2,952
  -3,090
  -3,235
  -3,388
  -3,550
  -3,720
  -3,898
  -4,086
  -4,284
  -4,492
Adjusted assets (=assets-cash), $m
  -1,397
  -1,429
  -1,466
  -1,507
  -1,553
  -1,603
  -1,657
  -1,717
  -1,780
  -1,848
  -1,922
  -2,000
  -2,083
  -2,171
  -2,264
  -2,364
  -2,469
  -2,580
  -2,697
  -2,821
  -2,952
  -3,090
  -3,235
  -3,388
  -3,550
  -3,720
  -3,898
  -4,086
  -4,284
  -4,492
Revenue / Adjusted assets
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
  -0.663
Average production assets, $m
  9,035
  9,242
  9,480
  9,747
  10,042
  10,366
  10,719
  11,102
  11,513
  11,955
  12,428
  12,932
  13,469
  14,040
  14,646
  15,288
  15,967
  16,685
  17,445
  18,246
  19,092
  19,984
  20,924
  21,914
  22,958
  24,056
  25,212
  26,429
  27,709
  29,055
Working capital, $m
  -4,323
  -4,423
  -4,536
  -4,664
  -4,805
  -4,961
  -5,130
  -5,312
  -5,509
  -5,721
  -5,947
  -6,188
  -6,445
  -6,719
  -7,008
  -7,315
  -7,641
  -7,984
  -8,348
  -8,731
  -9,136
  -9,563
  -10,013
  -10,487
  -10,986
  -11,511
  -12,065
  -12,647
  -13,259
  -13,904
Total debt, $m
  7,746
  7,746
  7,747
  7,748
  7,749
  7,750
  7,751
  7,753
  7,754
  7,756
  7,757
  7,759
  7,761
  7,763
  7,765
  7,767
  7,769
  7,772
  7,774
  7,777
  7,780
  7,783
  7,786
  7,789
  7,793
  7,797
  7,801
  7,805
  7,809
  7,814
Total liabilities, $m
  31
  31
  32
  33
  34
  35
  36
  38
  39
  41
  42
  44
  46
  48
  50
  52
  54
  57
  59
  62
  65
  68
  71
  75
  78
  82
  86
  90
  94
  99
Total equity, $m
  -1,428
  -1,460
  -1,498
  -1,540
  -1,587
  -1,638
  -1,694
  -1,754
  -1,819
  -1,889
  -1,964
  -2,044
  -2,128
  -2,219
  -2,314
  -2,416
  -2,523
  -2,637
  -2,757
  -2,883
  -3,017
  -3,158
  -3,306
  -3,463
  -3,628
  -3,801
  -3,984
  -4,176
  -4,379
  -4,591
Total liabilities and equity, $m
  -1,397
  -1,429
  -1,466
  -1,507
  -1,553
  -1,603
  -1,658
  -1,716
  -1,780
  -1,848
  -1,922
  -2,000
  -2,082
  -2,171
  -2,264
  -2,364
  -2,469
  -2,580
  -2,698
  -2,821
  -2,952
  -3,090
  -3,235
  -3,388
  -3,550
  -3,719
  -3,898
  -4,086
  -4,285
  -4,492
Debt-to-equity ratio
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
Adjusted equity ratio
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022
  1.022

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  77
  86
  96
  107
  120
  134
  149
  165
  182
  201
  221
  242
  265
  289
  314
  341
  370
  400
  433
  466
  502
  540
  579
  621
  665
  712
  761
  812
  866
  923
Depreciation, amort., depletion, $m
  903
  924
  948
  975
  1,004
  1,037
  1,072
  1,110
  1,151
  1,196
  1,243
  1,293
  1,347
  1,404
  1,465
  1,529
  1,597
  1,669
  1,744
  1,825
  1,909
  1,998
  2,092
  2,191
  2,296
  2,406
  2,521
  2,643
  2,771
  2,906
Funds from operations, $m
  981
  1,010
  1,044
  1,082
  1,124
  1,170
  1,220
  1,275
  1,333
  1,396
  1,463
  1,535
  1,612
  1,693
  1,779
  1,870
  1,967
  2,069
  2,177
  2,291
  2,411
  2,538
  2,672
  2,813
  2,961
  3,117
  3,282
  3,455
  3,637
  3,828
Change in working capital, $m
  -85
  -99
  -114
  -128
  -141
  -155
  -169
  -183
  -197
  -211
  -226
  -241
  -257
  -273
  -290
  -307
  -325
  -344
  -363
  -384
  -405
  -427
  -450
  -474
  -499
  -526
  -553
  -582
  -612
  -644
Cash from operations, $m
  1,066
  1,110
  1,158
  1,210
  1,266
  1,325
  1,389
  1,458
  1,530
  1,608
  1,690
  1,777
  1,869
  1,966
  2,069
  2,177
  2,292
  2,413
  2,540
  2,675
  2,816
  2,965
  3,122
  3,287
  3,460
  3,643
  3,835
  4,037
  4,249
  4,473
Maintenance CAPEX, $m
  -886
  -903
  -924
  -948
  -975
  -1,004
  -1,037
  -1,072
  -1,110
  -1,151
  -1,196
  -1,243
  -1,293
  -1,347
  -1,404
  -1,465
  -1,529
  -1,597
  -1,669
  -1,744
  -1,825
  -1,909
  -1,998
  -2,092
  -2,191
  -2,296
  -2,406
  -2,521
  -2,643
  -2,771
New CAPEX, $m
  -173
  -208
  -238
  -267
  -295
  -324
  -353
  -382
  -412
  -442
  -473
  -504
  -537
  -571
  -606
  -642
  -679
  -718
  -759
  -802
  -846
  -892
  -940
  -991
  -1,043
  -1,098
  -1,156
  -1,217
  -1,280
  -1,346
Cash from investing activities, $m
  -1,059
  -1,111
  -1,162
  -1,215
  -1,270
  -1,328
  -1,390
  -1,454
  -1,522
  -1,593
  -1,669
  -1,747
  -1,830
  -1,918
  -2,010
  -2,107
  -2,208
  -2,315
  -2,428
  -2,546
  -2,671
  -2,801
  -2,938
  -3,083
  -3,234
  -3,394
  -3,562
  -3,738
  -3,923
  -4,117
Free cash flow, $m
  6
  -1
  -4
  -5
  -5
  -3
  0
  4
  9
  14
  21
  29
  38
  48
  59
  71
  84
  98
  113
  129
  146
  164
  183
  204
  226
  249
  273
  299
  326
  355
Issuance/(repayment) of debt, $m
  1
  1
  1
  1
  1
  1
  1
  1
  1
  2
  2
  2
  2
  2
  2
  2
  2
  2
  3
  3
  3
  3
  3
  3
  4
  4
  4
  4
  4
  5
Issuance/(repurchase) of shares, $m
  -27
  -33
  -38
  -42
  -47
  -51
  -56
  -60
  -65
  -70
  -75
  -80
  -85
  -90
  -96
  -101
  -107
  -114
  -120
  -127
  -134
  -141
  -149
  -157
  -165
  -174
  -183
  -192
  -202
  -213
Cash from financing (excl. dividends), $m  
  -26
  -32
  -37
  -41
  -46
  -50
  -55
  -59
  -64
  -68
  -73
  -78
  -83
  -88
  -94
  -99
  -105
  -112
  -117
  -124
  -131
  -138
  -146
  -154
  -161
  -170
  -179
  -188
  -198
  -208
Total cash flow (excl. dividends), $m
  -20
  -34
  -41
  -46
  -50
  -53
  -55
  -56
  -55
  -54
  -52
  -49
  -45
  -40
  -35
  -28
  -21
  -13
  -5
  5
  15
  26
  38
  51
  64
  79
  94
  111
  129
  147
Retained Cash Flow (-), $m
  27
  33
  38
  42
  47
  51
  56
  60
  65
  70
  75
  80
  85
  90
  96
  101
  107
  114
  120
  127
  134
  141
  149
  157
  165
  174
  183
  192
  202
  213
Prev. year cash balance distribution, $m
  1,401
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  15
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  30
  32
  33
  35
  36
  38
  40
  42
  44
  46
  48
Cash available for distribution, $m
  1,408
  33
  38
  42
  47
  51
  56
  60
  65
  70
  75
  80
  85
  90
  96
  101
  107
  114
  120
  131
  148
  167
  186
  207
  229
  252
  277
  303
  331
  360
Discount rate, %
  14.40
  15.12
  15.88
  16.67
  17.50
  18.38
  19.30
  20.26
  21.28
  22.34
  23.46
  24.63
  25.86
  27.15
  28.51
  29.94
  31.43
  33.01
  34.66
  36.39
  38.21
  40.12
  42.12
  44.23
  46.44
  48.76
  51.20
  53.76
  56.45
  59.27
PV of cash for distribution, $m
  1,230
  25
  24
  23
  21
  19
  16
  14
  11
  9
  7
  6
  4
  3
  2
  2
  1
  1
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Current shareholders' claim on cash, %
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

Omega Healthcare Investors, Inc. is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties. It provides lease or mortgage financing to qualified operators of skilled nursing facilities (SNFs) and assisted living facilities (ALFs), independent living facilities, rehabilitation and acute care facilities. Its portfolio consists of long-term leases and mortgage agreements. As of December 31, 2016, its portfolio of investments included 996 healthcare facilities located in 42 states and the United Kingdom and operated by 79 third-party operators. As of December 31, 2016, the Company's portfolio consisted of 809 SNFs, 101 ALFs, 16 specialty facilities, one medical office building, fixed rate mortgages on 44 SNFs and two ALFs.

FINANCIAL RATIOS  of  Omega Healthcare Investors (OHI)

Valuation Ratios
P/E Ratio 17.5
Price to Sales 7.1
Price to Book 1.7
Price to Tangible Book
Price to Cash Flow 10.3
Price to Free Cash Flow -15.9
Growth Rates
Sales Growth Rate 21.1%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 124.7%
Cap. Spend. - 3 Yr. Gr. Rate 99%
Financial Strength
Quick Ratio NaN
Current Ratio NaN
LT Debt to Equity 113.2%
Total Debt to Equity 113.2%
Interest Coverage 4
Management Effectiveness
Return On Assets 6.1%
Ret/ On Assets - 3 Yr. Avg. 7.1%
Return On Total Capital 4.7%
Ret/ On T. Cap. - 3 Yr. Avg. 5%
Return On Equity 9.6%
Return On Equity - 3 Yr. Avg. 11.6%
Asset Turnover 0.1
Profitability Ratios
Gross Margin 0%
Gross Margin - 3 Yr. Avg. 0%
EBITDA Margin 88.7%
EBITDA Margin - 3 Yr. Avg. 86.1%
Operating Margin 56.6%
Oper. Margin - 3 Yr. Avg. 60.2%
Pre-Tax Margin 42.6%
Pre-Tax Margin - 3 Yr. Avg. 39.3%
Net Profit Margin 40.6%
Net Profit Margin - 3 Yr. Avg. 38.2%
Effective Tax Rate 0.3%
Eff/ Tax Rate - 3 Yr. Avg. 0.4%
Payout Ratio 129.5%

OHI stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the OHI stock intrinsic value calculation we used $908 million for the last fiscal year's total revenue generated by Omega Healthcare Investors. The default revenue input number comes from 2017 income statement of Omega Healthcare Investors. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our OHI stock valuation model: a) initial revenue growth rate of 2% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 14.4%, whose default value for OHI is calculated based on our internal credit rating of Omega Healthcare Investors, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Omega Healthcare Investors.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of OHI stock the variable cost ratio is equal to 43.4%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for OHI stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for Omega Healthcare Investors.

Corporate tax rate of 27% is the nominal tax rate for Omega Healthcare Investors. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the OHI stock is equal to 1.7%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for OHI are equal to 975.5%.

Life of production assets of 10 years is the average useful life of capital assets used in Omega Healthcare Investors operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for OHI is equal to -466.8%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $0 million for Omega Healthcare Investors - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 198 million for Omega Healthcare Investors is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Omega Healthcare Investors at the current share price and the inputted number of shares is $6.5 billion.

RELATED COMPANIES Price Int.Val. Rating
SBRA Sabra Healthca 23.26 104.19  str.buy
CTRE CareTrust REIT 18.12 621.03  str.buy
LTC LTC Properties 45.82 4.38  str.sell
DOC Physicians Rea 17.43 558.19  str.buy
HCP HCP 27.22 7.81  str.sell
HR Healthcare Rea 30.79 112.15  str.buy
UHT Universal Heal 73.83 5.26  str.sell
VTR Ventas 59.67 529.24  str.buy

COMPANY NEWS

▶ Signature Healthcare landlord: 'Things are going well' after restructuring   [Aug-10-18 02:02PM  American City Business Journals]
▶ Omega Healthcare Investors: 2Q Earnings Snapshot   [04:46PM  Associated Press]
▶ [$$] Orianna Asks Judge to Revisit Key Landlord Controversy   [Jul-30-18 05:19PM  The Wall Street Journal]
▶ 3 Top Dividend Stocks With Yields Over 5%   [Jul-19-18 12:00PM  Motley Fool]
▶ [$$] Orianna Health Defends Chapter 11 Bankruptcy Plan   [Jul-06-18 02:59PM  The Wall Street Journal]
▶ Five Best Healthcare REITs to Buy Now   [Jun-14-18 06:00AM  Investopedia]
▶ Ho, Ho, Ho It's REIT Magic   [Jun-11-18 07:45AM  Forbes]
▶ 3 Stocks to Help You Build Retirement Wealth   [May-23-18 08:03AM  Motley Fool]
▶ Schlumberger Is Among 7 Stocks Ready to Change Direction   [May-14-18 02:10PM  TheStreet.com]
▶ Omega Announces 2018 Investor Day Webcast   [May-11-18 09:42AM  Business Wire]
▶ [$$] Trial Begins on Orianna Restructuring Decried by Creditors   [May-08-18 05:45PM  The Wall Street Journal]
▶ Signature Healthcare reaches out-of-court settlement with landlords   [01:04PM  American City Business Journals]
▶ Omega Healthcare Investors: 1Q Earnings Snapshot   [06:09PM  Associated Press]
▶ 3 Top Dividend Stocks With Yields Over 4%   [Apr-27-18 07:49PM  Motley Fool]
▶ [$$] Orianna Health Restructuring Faces Creditor Backlash   [Apr-12-18 04:23PM  The Wall Street Journal]
▶ 3 Huge Healthcare Dividends: Are They Too Hot to Handle?   [Mar-28-18 08:41AM  Motley Fool]
▶ Best-In-Class Real Estate Dividend Stocks   [Mar-26-18 11:02AM  Simply Wall St.]
▶ [$$] Orianna Health Systems Seeks OK of Settlement With Landlord   [Mar-14-18 02:33PM  The Wall Street Journal]
▶ New Strong Sell Stocks for February 20th   [Feb-20-18 08:24AM  Zacks]
▶ 2 Stocks Moving Wednesday   [Feb-14-18 04:29PM  GuruFocus.com]
▶ Omega Healthcare Investors reports 4Q results   [Feb-13-18 07:42PM  Associated Press]
▶ Best-In-Class Real Estate Dividend Stocks   [10:02AM  Simply Wall St.]
▶ 3 Unknown but Amazing Dividend Stocks   [Jan-29-18 03:55PM  Motley Fool]
▶ 3 High-Yield Stocks to Hold Forever   [Jan-15-18 11:07AM  Motley Fool]
Follow us on:   twitter   twitter   twitter   twitter

ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.